Schedule 13G ownership disclosure

Aytu BioPharma Inc

Common Stock · CUSIP: 054754858

Event date: 2025-06-09

Filing-level shares
506,605.00
Percent of class
5.6%
  • LYTTON LAURENCE W

    Shares: 506,605.00 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000423
Form type
SCHEDULE 13G
Filer
AYTU BIOPHARMA, INC
CIK
CIK 1385818
Filed
Jun 13, 2025
Reporting period
Jun 09, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub